Myocardial perfusion imaging in identifying a low-risk group after acute myocardial infarction

Cardiology Review

Volumn 24, Issue 7, 2007, Pages 19-24

  Mahmarian, John J ^a   Pratt, Craig M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEMALE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART REINFARCTION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVOR;

EID: 34447525396     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wiviott SD, Morrow DA, Frederick PD, et al. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004;44(4):783-789.
2. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879-1887.
3. Invasive compared with non-invasive treatment in unstable coronary artery disease. FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Lancet. 1999;354(9180):708-715.
4. Dakik HA, Mahmarian JJ, Kimball KT, et al. Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation. 1996;94(11):2735-2742.
5. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation. 1999;100(20):2060-2066.
6. Mahmarian JJ, Shaw LJ, Olszewski GH, et al for the INSPIRE Investigators. Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: a randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction. J Nucl Cardiol. 2004;11(4):458-469.
7. Mahmarian JJ, Shaw LJ, Filipchuk NG, et al for the INSPIRE Investigators. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol. 2006;48(12):2448-2457.
8. Mahmarian JJ, Dakik HA, Filipchuk NG, et al for the INSPIRE Investigators. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;48(12):2458-2467.
9. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998;338(25):1785-1792.
10. Barnett PG, Chen S, Boden WE, et al. Cost effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation. 2002;105(6):680-684.
11. Gibson RS, Beller GA, Gheorghiade M, et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q-wave infarction: a prospective natural history study. Circulation. 1986;73(6):1186-1198.
12. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290(12):1593-1599.
13. Mahoney EM, Jurkovitz CT, Chu H, et al. Cost and cost effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 2002;288(12):1851-1858.
14. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151-1158.
15. Hochman JS, Lamas GA, Buller CE, et al. for the Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23):2395-2407.
16. Mahmarian JJ. Risk stratification after acute ST-segment elevation myocardial infarction. In: Beller GA, Zaret BL, eds. Nuclear Cardiology: State of the Art and Future Directions. 3rd ed. Philadelphia, Pa: Elsevier; 2004:453-478.
17. de Winter RJ, Windhausen F, Cornel JH, et al for the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353(11):1095-1104.